Factor VIII
Factor VIII is catalogued here under the VWF gene, which encodes von Willebrand factor (F8VWF), a secreted glycoprotein central to haemostasis. It bridges platelets to damaged vessel walls and acts as a chaperone that carries coagulation factor VIII in the blood. Browse Assay Genie's current range of Factor VIII research reagents below, or read on for the biology behind the target.
The VWF gene encodes von Willebrand factor, a glycoprotein that is important in maintaining haemostasis. At sites of vascular injury it promotes the adhesion of platelets by forming a molecular bridge between the sub-endothelial collagen matrix and the platelet-surface receptor complex GPIb-IX-V. This bridging role makes it a key link between the damaged vessel wall and the first stage of platelet plug formation.
The same protein also acts as a chaperone for coagulation factor VIII. It delivers factor VIII to the site of injury, stabilises its heterodimeric structure and protects it from premature clearance from plasma. This is why the two proteins are so often studied together, and why Factor VIII work frequently involves the VWF gene product as well. The encoded preproprotein is proteolytically processed after assembly into large multimeric complexes, which function both in platelet adhesion and in the transport of various proteins in the blood. UniProt records the mature protein as secreted, including in the extracellular matrix.
Mutations in the VWF gene result in von Willebrand disease, an inherited bleeding disorder. HGNC classifies the gene within the receptor ligands group and lists F8VWF as an alias. An unprocessed pseudogene has been found on chromosome 22. Mouse and rat both carry a Vwf ortholog, which allows the biology of this protein to be examined in common rodent models.
Von Willebrand factor promotes platelet adhesion at vascular injury, so it is a central protein for studying how the haemostatic response begins.
As the chaperone that stabilises factor VIII and protects it from premature clearance, it is relevant to studies of factor VIII transport and persistence in plasma.
It links sub-endothelial collagen to the GPIb-IX-V receptor complex, providing a defined ligand-receptor bridge for adhesion research.
Mutations in VWF cause von Willebrand disease, making the gene and protein a focus for research into inherited bleeding.
Von Willebrand factor promotes platelet adhesion at sites of vascular injury by bridging sub-endothelial collagen and the platelet GPIb-IX-V receptor complex. It also chaperones coagulation factor VIII, stabilising its heterodimeric structure and protecting it from premature clearance from plasma.
The VWF gene, also known as F8VWF, encodes the protein that binds and carries factor VIII in plasma. The two proteins work closely together in haemostasis, so this page covers the VWF gene product that delivers and protects factor VIII.
Mouse and rat each have a Vwf ortholog. In humans, mutations in the VWF gene result in von Willebrand disease, an inherited bleeding disorder. Check the datasheet of any product for its validated reactivity.
Coagulation factor, platelet receptor and haemostasis-related targets that connect with von Willebrand factor biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P04275; product specifications from Assay Genie datasheets.